Entera Bio Ltd Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Entera Bio Ltd   (NASDAQ: ENTX)

ENTX's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Y / Y Equity Change 62.14 % -22.2 % -11.64 % -47.91 % 200.47 %
Y / Y Net Income Change 19.89 % 7.33 % -31.99 % 7.25 % -
Return On Equity 87.31 % 118.08 % 85.59 % 111.2 % 54.01 %


You need to upgrade your Flash Player


Roe Comment
In (Dec 31 2025) ROE detoriated to 87.31 %, despite net income growth.


Financial Statements
Entera Bio Ltd 's Equity $ 13 Millions Annual ENTX's Balance sheet
Entera Bio Ltd 's Annual Income $ 11 Millions Annual ENTX's Income Statement
Where are ENTX's Income coming from? Visit ENTX's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.